ITP (immune thrombocytopenia) is an autoimmune disorder where the body attacks its own blood platelets. This leads to a decrease in the number of platelets and consequently can cause a number of ...

KFDA approves immune thrombocytopenia treatment Tavalisse from Rigel Pharmaceuticals KFDA greenlights Tavalisse, a groundbreaking therapy for rare platelet disorder by Rigel Pharmaceuticals.

Grifols – a Barcelona-based specialist in plasma-based therapies – said today that Tavlesse is the first and only SYK inhibitor for patients with ITP, an autoimmune clotting disorder that ...

GALAX — Twin County Regional Healthcare has announced that Crystal Caudell, a nurse in the Cardiac Rehab department, has been ...

Finally, potential stimulation of TPO-Rs on leukemic stem cells in individuals with thrombocytopenia and an underlying bone marrow disease, such as myelodysplastic syndrome, remains a lingering ...

Doptelet (avatrombopag) – an oral thrombopoietin receptor agonist – has been cleared to boost depleted levels of platelets in the blood of patients with ITP, an autoimmune clotting disorder ...

For the first time, United Hospital Center (UHC) in Bridgeport presented DAISY awards to three nurses on Thursday.

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with biotechnology startup FcR Therapeutics to develop recombinant nanobodies ...